Sarcopenia index based on serum creatinine and cystatin C predicts the risk of postoperative complications following hip fracture surgery in older adults
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2318
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Sarcopenia index based on serum creatinine and cystatin C predicts the risk of postoperative complications following hip fracture surgery in older adults ; volume:21 ; number:1 ; day:12 ; month:10 ; year:2021 ; pages:1-7 ; date:12.2021
BMC geriatrics ; 21, Heft 1 (12.10.2021), 1-7, 12.2021
- Creator
-
Chen, Xiaoyan
Shen, Yanjiao
Hou, Lisha
Yang, Binyu
Dong, Birong
Hao, Qiukui
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12877-021-02522-1
- URN
-
urn:nbn:de:101:1-2021122618132240603008
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Xiaoyan
- Shen, Yanjiao
- Hou, Lisha
- Yang, Binyu
- Dong, Birong
- Hao, Qiukui
- SpringerLink (Online service)
Other Objects (12)
Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer
Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis
Radiographic sarcopenia predicts postoperative infectious complications in patients undergoing pancreaticoduodenectomy
Relationships between cystatin C- and creatinine-based eGFR in Japanese rural community- dwelling older adults with sarcopenia
Serum creatinine/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer
Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study
A sarcopenia index based on serum creatinine and cystatin C cannot accurately detect either low muscle mass or sarcopenia in urban community-dwelling older people
Creatinine-to-cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
Sarcopenia diagnosed by computed tomography predicts postoperative complications in advanced epithelial ovarian cancer
Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
Two elderly patients with normal creatinine and elevated cystatin C – a case report
Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer
Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis
Radiographic sarcopenia predicts postoperative infectious complications in patients undergoing pancreaticoduodenectomy
Relationships between cystatin C- and creatinine-based eGFR in Japanese rural community- dwelling older adults with sarcopenia
Serum creatinine/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer
Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study
A sarcopenia index based on serum creatinine and cystatin C cannot accurately detect either low muscle mass or sarcopenia in urban community-dwelling older people
Creatinine-to-cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
Sarcopenia diagnosed by computed tomography predicts postoperative complications in advanced epithelial ovarian cancer
Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
Two elderly patients with normal creatinine and elevated cystatin C – a case report
Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer
Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis
Radiographic sarcopenia predicts postoperative infectious complications in patients undergoing pancreaticoduodenectomy
Relationships between cystatin C- and creatinine-based eGFR in Japanese rural community- dwelling older adults with sarcopenia
Serum creatinine/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer
Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study
A sarcopenia index based on serum creatinine and cystatin C cannot accurately detect either low muscle mass or sarcopenia in urban community-dwelling older people
Creatinine-to-cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
Sarcopenia diagnosed by computed tomography predicts postoperative complications in advanced epithelial ovarian cancer
Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus